- Home
- SVV vs PSNL Comparison
SVV vs PSNL Comparison
Compare SVV & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SVV | PSNL |
|---|---|---|
| Founded | 1954 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.1B |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SVV | PSNL |
|---|---|---|
| Price | $10.22 | $10.85 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $13.67 | $12.20 |
| AVG Volume (30 Days) | 919.3K | ★ 3.0M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 33.58 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,678,954,000.00 | $69,648,000.00 |
| Revenue This Year | $6.91 | $15.34 |
| Revenue Next Year | $7.80 | $41.46 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 9.19 | N/A |
| 52 Week Low | $6.91 | $3.84 |
| 52 Week High | $13.89 | $12.53 |
Technical Indicators
Market Signals| Indicator | SVV | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 64.16 | 62.62 |
| Support Level | $10.13 | $7.26 |
| Resistance Level | $10.99 | $11.28 |
| Average True Range (ATR) | 0.45 | 0.98 |
| MACD | 0.02 | -0.10 |
| Stochastic Oscillator | 95.33 | 52.17 |
Price Performance
Historical ComparisonAbout SVV Savers Value Village Inc.
Savers Value Village Inc is a for-profit thrift operator in the United States and Canada. It purchases second-hand textiles (i.e., clothing, bedding, and bath items), shoes, accessories, housewares, books, and other goods from its non-profit partners (NPPs), either directly from them or via on-site donations (OSDs) at Community Donation Centers at its stores. The company then processes, selects, prices, and sells these items in its stores.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.